Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma

Fig. 5

Ex-vivo evaluation of the immunological recruitment at tumor site. A Upper panel: IF to evaluate CD14 protein in the two experimental groups (AT101 treated mice and unspecific IgM treated mice). In green the signal related to CD14 protein and in blue the nuclei. Scale bar: 100 µm. Lower panel: bar chart representing the quantification of fluorescence, data are expressed as normalized fluorescence (protein/nuclei). B Upper panel: IF to evaluate CD56 protein in the two experimental groups (AT101 treated mice and unspecific IgM treated mice). In green the signal related to CD56 protein and in blue the nuclei. Scale bar: 100 µm. Lower panel: bar chart representing the quantification of fluorescence, data are expressed as normalized fluorescence (protein/nuclei)

Back to article page